Skip to content
MedsAcross

Medicine

Alcaine 5 mg/mL eye drops

Proparacaine · Ophthalmic · Alcon Laboratories
Available on requestPrescription onlyUS FDA Cold chain

Alcaine 5 mg/mL eye drops is a prescription medicine containing Proparacaine for ophthalmic use, marketed by Alcon Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Store bottles under refrigeration at 2°C to 8°C (36°F to 46°F). Bottle must be…

Key facts

Active ingredient (INN)
Proparacaine
Brand
Alcaine
Strength
5 mg/mL
Dosage form
Eye drops
Route
Ophthalmic
Packs
1 bottle
Marketing authorisation holder
Alcon Laboratories
Manufacturer
Alcon Laboratories
Origin register
US FDA, United States
Storage
Store bottles under refrigeration at 2°C to 8°C (36°F to 46°F). Bottle must be stored in unit carton to protect contents from light.
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
S01HA04 Proparacaine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
19 October 1973
Identifiers
RxCUI 1191013, 1191026DailyMed set ID 0c0fa0bf-977d-4539-b8dc-54c187c5b094NDC 0998-0016Application ANDA080027

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 bottle in 1 carton / 15 mL in 1 bottle0998-0016-15Alcon Laboratories19 October 1973

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 1 July 1953Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Proparacaine 5 mg/mL eye drops.

Compare 1

Clinical summary

Proparacaine is a local anesthetic indicated for procedures in which a topical ophthalmic anesthetic is indicated. It is available as eye drops for ophthalmic use. MedsAcross supplies Proparacaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Proparacaine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Alcaine 5 mg/mL eye drops for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.